Treatment with EPCs attenuates the kidney injury of AKI SCID mice; ex vivo pretreatment of EPCs with SDF-1 abrogates the therapeutic effect of EPCs that were injected into AKI SCID mice, but it was rescued by the presence of ex vivo FGF23. Here, CXCL12 is linked to acute kidney injury.